PolyPid (PYPD) Competitors $3.74 -0.02 (-0.53%) Closing price 07/24/2025 04:00 PM EasternExtended Trading$3.76 +0.01 (+0.40%) As of 07/24/2025 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PYPD vs. LAKE, LUCD, INFU, OBIO, AVR, LUNG, ICAD, FONR, ZJYL, and MBOTShould you be buying PolyPid stock or one of its competitors? The main competitors of PolyPid include Lakeland Industries (LAKE), Lucid Diagnostics (LUCD), InfuSystem (INFU), Orchestra BioMed (OBIO), Anteris Technologies Global (AVR), Pulmonx (LUNG), icad (ICAD), Fonar (FONR), Jin Medical International (ZJYL), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry. PolyPid vs. Its Competitors Lakeland Industries Lucid Diagnostics InfuSystem Orchestra BioMed Anteris Technologies Global Pulmonx icad Fonar Jin Medical International Microbot Medical Lakeland Industries (NASDAQ:LAKE) and PolyPid (NASDAQ:PYPD) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment. Is LAKE or PYPD more profitable? PolyPid has a net margin of 0.00% compared to Lakeland Industries' net margin of -13.31%. Lakeland Industries' return on equity of -6.88% beat PolyPid's return on equity.Company Net Margins Return on Equity Return on Assets Lakeland Industries-13.31% -6.88% -4.47% PolyPid N/A -1,069.37%-151.85% Do institutionals & insiders believe in LAKE or PYPD? 71.7% of Lakeland Industries shares are owned by institutional investors. Comparatively, 26.5% of PolyPid shares are owned by institutional investors. 1.9% of Lakeland Industries shares are owned by insiders. Comparatively, 24.7% of PolyPid shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has higher earnings & valuation, LAKE or PYPD? Lakeland Industries has higher revenue and earnings than PolyPid. Lakeland Industries is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeland Industries$167.21M0.84-$18.08M-$3.01-4.93PolyPidN/AN/A-$29.02M-$4.30-0.87 Which has more risk and volatility, LAKE or PYPD? Lakeland Industries has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, PolyPid has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Does the media prefer LAKE or PYPD? In the previous week, Lakeland Industries had 5 more articles in the media than PolyPid. MarketBeat recorded 6 mentions for Lakeland Industries and 1 mentions for PolyPid. PolyPid's average media sentiment score of 1.89 beat Lakeland Industries' score of 0.38 indicating that PolyPid is being referred to more favorably in the news media. Company Overall Sentiment Lakeland Industries Neutral PolyPid Very Positive Do analysts recommend LAKE or PYPD? Lakeland Industries currently has a consensus price target of $26.00, indicating a potential upside of 75.20%. PolyPid has a consensus price target of $11.80, indicating a potential upside of 215.51%. Given PolyPid's stronger consensus rating and higher possible upside, analysts clearly believe PolyPid is more favorable than Lakeland Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lakeland Industries 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00PolyPid 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 SummaryPolyPid beats Lakeland Industries on 9 of the 16 factors compared between the two stocks. Get PolyPid News Delivered to You Automatically Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYPD vs. The Competition Export to ExcelMetricPolyPidMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.32M$2.77B$5.73B$9.48BDividend YieldN/A1.78%4.60%3.99%P/E Ratio-0.879.1227.9319.95Price / SalesN/A736.29440.29101.76Price / CashN/A166.2336.5558.97Price / Book4.995.228.645.90Net Income-$29.02M$30.99M$3.24B$258.42M7 Day Performance3.31%4.60%3.73%2.12%1 Month PerformanceN/A12.70%10.35%12.46%1 Year Performance6.86%-0.48%34.25%19.56% PolyPid Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYPDPolyPid2.3841 of 5 stars$3.74-0.5%$11.80+215.5%+7.2%$38.32MN/A-0.8780LAKELakeland Industries4.7504 of 5 stars$13.78-3.7%$26.00+88.7%-36.6%$131.12M$177.65M-4.582,100High Trading VolumeLUCDLucid Diagnostics2.8361 of 5 stars$1.17+2.6%$3.55+203.4%+29.4%$126.58M$4.17M-0.8770Positive NewsINFUInfuSystem3.3205 of 5 stars$5.61-3.3%$13.00+131.7%N/A$117.90M$137.58M93.52410News CoverageAnalyst ForecastAnalyst RevisionOBIOOrchestra BioMed2.403 of 5 stars$3.03+3.8%$14.20+368.6%-59.8%$116.08M$2.64M-1.704News CoveragePositive NewsAVRAnteris Technologies GlobalN/A$3.07-3.5%$16.50+437.5%N/A$110.71M$2.49M0.00138LUNGPulmonx3.1333 of 5 stars$2.68-7.6%$11.53+330.0%-60.0%$107.90M$83.79M-1.86250Upcoming EarningsGap UpICADicad1.0881 of 5 stars$3.82+2.1%N/AN/A$104.94M$19.53M-20.11140FONRFonar1.3486 of 5 stars$16.31+2.9%N/A-14.0%$101.17M$103.02M13.05480High Trading VolumeZJYLJin Medical InternationalN/A$0.60-6.0%N/A-80.2%$94.21M$23.50M0.00245Positive NewsGap UpMBOTMicrobot Medical2.1223 of 5 stars$2.52-3.8%$9.00+257.1%+168.6%$91.67MN/A-3.8820Gap Up Related Companies and Tools Related Companies Lakeland Industries Alternatives Lucid Diagnostics Alternatives InfuSystem Alternatives Orchestra BioMed Alternatives Anteris Technologies Global Alternatives Pulmonx Alternatives icad Alternatives Fonar Alternatives Jin Medical International Alternatives Microbot Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYPD) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyPid Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolyPid With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PYPD Stock Alerts